| 4:00–8:00 PM | Arrival and Registration | INEC Foyer |
| 6:00–8:00 PM | Welcome Mixer | INEC Foyer |
| 7:00–8:00 AM | Breakfast | Individual Hotel |
| 8:00–9:00 AM | Welcome and Keynote Address | INEC Main Auditorium |
| * Miriam Merad, Mount Sinai School of Medicine Session Chair |
| * Matthew F. Krummel, University of California, San Francisco Session Chair |
| Martin Guilliams, Ghent University - VIB DC and Macrophage Diversity in Health and Diseases |
| 9:00–11:15 AM | Developmental Regulation of Myeloid Cells in Cancer and Beyond | INEC Main Auditorium |
| Miriam Merad, Mount Sinai School of Medicine Enhancing DC Function in the TME |
| * Christine Carine Moussion, Genentech, Inc. Spatial Organization of Myeloid Programs in the TME |
| Merav Cohen, Tel-Aviv University Myeloid Cellular Cross-Talks During Cancer Development |
| Robert Samstein, Icahn School of Medicine at Mount Sinai Short Talk: Short Talk: HLA Class II Mediated Immune Surveillance of Lung Cancer |
| 9:30–9:50 AM | Coffee Break | INEC Foyer |
| 11:15–1:00 PM | Poster Setup | INEC Foyer |
| 11:15–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing | INEC Foyer |
| 3:30–4:30 PM | Career Roundtable | INEC Main Auditorium |
| Judith A. Varner, University of California, San Diego Professor, Pathology |
| Venkataraman Sriram, Foundery Innovations Founder, Managing Member, & Chief Scientific Officer |
| Matteo Iannacone, San Raffaele Scientific Institute & University Group Leader |
| 4:30–5:00 PM | Coffee Available | INEC Foyer |
| 5:00–7:00 PM | Enhancing DC Functionality in the TME | INEC Main Auditorium |
| * Matthew F. Krummel, University of California, San Francisco Session Chair |
| * Miriam Merad, Mount Sinai School of Medicine Session Chair |
| Rony Dahan, Weizmann Institute of Science Antibody Targeting of Dendritic Cells in Cancer |
| Ruth Lan, Asher Biotherapeutics Cell-Specific Cytokine Delivery |
| Livia Lacerda Mariano, Institute Curie Short Talk: Short Talk: The TRPML1 Calcium Lysosomal Channel Controls Dendritic Cell Migration and Anti-tumor Immunity |
| Raphael Mattiuz, Icahn School of Medicine at Mount Sinai Short Talk: Short Talk: Dendritic Cells Form and Maintain Tertiary Lymphoid Structures (TLSs) in Cancer Contributing to Immunotherapeutic Responses |
| 7:00–8:00 PM | Social Hour with Lite Bites | INEC Foyer |
| 7:30–10:00 PM | Poster Session 1 | INEC Foyer |
| 7:00–8:00 AM | Breakfast | Individual Hotel |
| 8:00–11:00 AM | Boosting Macrophage Tumorigenic Function | INEC Main Auditorium |
| * Julie Helft, Institut Cochin FOLR2+ Macs and Antitumor Immunity |
| Jennifer Guerriero, Brigham and Women's Hospital Metabolic Targeting of Tumor Macrophages |
| * Philippe Benaroch, INSERM Institut Curie Myeloid Cell Engineering for Anti-Tumor Treatments |
| Ido Amit, Weizmann Institute Mapping Macrophages Inflammatory Programs |
| Florent Ginhoux, Singapore Immunology Network Regulation of Monocyte-Derived Cells Differentiation in Inflamed Tissues |
| Meijun Wang, City University of Hong Kong (Shenzhen) Research Institute Short Talk: Short Talk: Investigate the Role of IRF5 in Macrophages and Myeloid Cells in Anti-Tumor Immunity |
| Lea Feldmann, Institut Pasteur Short Talk: Short Talk: Understanding the Antitumoral Activity of CAR-Macrophages |
| 9:00–9:20 AM | Coffee Break | INEC Foyer |
| 11:00–1:00 PM | Poster Setup | INEC Foyer |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing | INEC Foyer |
| 2:30–4:30 PM | Workshop | INEC Main Auditorium |
| Dalton Hermans, National Institutes of Health ACT-VAX-INNATE: An Integrated Approach for Enhancing Tumor Control with Adoptive T Cell Therapy |
| * Alexander B. Sigalov, SignaBlok, Inc. Ligand-Independent TREM-1 Blockade in Cancer Treatment |
| Thomas Jaquin, IOmx Therapeutics AG IOMX-0675 , a LILRB1 and LILRB2 Cross-Specific Antibody, Effectively Repolarizes Immunosuppressive Myeloid Cells and Activates T Cells Leading to Potent Tumor Cell Killing |
| Martina Molgora, Washington University School of Medicine Lack of TREM2 During anti-PD1 Therapy Reprograms Intestinal Macrophages and Microbiota to Enhance Tumor Rejection |
| Daniela C Cerezo-Wallis, Yale University Cancer Enables Auxiliary Pathways of Granulopoiesis to Potentiate Tumorassociated Neutrophils |
| * Damya Laoui, Vrije Universiteit Brussel-VIB Intratumoral Delivery of Lipid Nanoparticle-Formulated mRNA Encoding IL-21, IL-7, and 4-1BBL Induces Anti-Tumor Immunity |
| Cristina Contreras Burrola, National Cancer Institute Going the Distance: Uncovering a Global Myeloid Reprogramming in Human Metastatic and Adjacent Microenvironments |
| Garett Dunsmore, University of Paris Saclay Timing and Location Dictate Monocyte Fate and Their Transition to Tumor-Associated Macrophages |
| 4:30–5:00 PM | Coffee Available | INEC Foyer |
| 5:00–7:00 PM | Dampening Myeloid Regulatory Programs | INEC Main Auditorium |
| * Martin Guilliams, Ghent University - VIB Session Chair |
| Venkataraman Sriram, Foundery Innovations Targeting Trem2 in Cancer Patients |
| * Judith A. Varner, University of California, San Diego Targeting Immunosupressive Macrophages |
| Megan Clark, UPenn Short Talk: Short Talk: Mitochondrial NDUFA4 is a Functional Switch Controlling TAM Function and Tumor Immunity |
| Nicoletta Caronni, Ospedale San Raffaele Short Talk: Short Talk: IL-1β+ Macrophages Fuel Pathogenic Inflammation in Pancreatic Cancer |
| Matthew Arvedson, UCSF Short Talk: Short Talk: Aire-Expressing Tumor-Associated Macrophages Promote Cancer Immune Evasion |
| Samarth Hegde, Icahn School of Medicine at Mount Sinai Short Talk: Short Talk: Epigenetic Dysregulation of Myeloid Progenitors Fuel Immunosuppressive Macrophages in Tumor Microenvironment |
| 7:00–8:00 PM | Social Hour with Lite Bites | INEC Foyer |
| 7:30–10:00 PM | Poster Session 2 | INEC Foyer |
| 7:00–8:00 AM | Breakfast | Individual Hotel |
| 8:00–11:00 AM | Myeloid Cell Control of the Tissue Ecosystem | INEC Main Auditorium |
| * Matthew F. Krummel, University of California, San Francisco Space-Time 'Movements' in Tissues |
| * Laurence Zitvogel, Institut Gustave Roussy Bile Acids Module the Gut Immune Rheostat Tuning Cancer Immunosurveillance |
| Luke A. J. O'Neill, Trinity Biomedical Sciences Institute A Break in Mitochondrial Endosymbiosis as a Basis for Inflammatory Diseases |
| Jo A. Van Ginderachter, Vrije Universiteit Brussel Short Talk: Short Talk: Kupffer Cell-Derived MIF as Regulator of Liver Metastasis |
| Ayumi Kuratani, Osaka University Short Talk: Short Talk: Identification of a Tumor-Specific Macrophage Subset and its Functional Analysis by Labeling and Depletion Using the Novel VeDTR Mouse System |
| 9:00–9:20 AM | Coffee Break | INEC Foyer |
| 11:00–5:00 PM | On Own for Lunch |
| 4:30–5:00 PM | Coffee Available | INEC Foyer |
| 5:00–6:45 PM | Myeloid Cells in Viral and Inflammatory Diseases | INEC Main Auditorium |
| * Matteo Iannacone, San Raffaele Scientific Institute & University Targeting Myeloid Cells in Viral Diseases |
| * Carla V. Rothlin, Yale University Myeloid and Stromal Crosstalk in Non-Resolving Inflammation |
| Duale A Ahmed, Carleton University Short Talk: Short Talk: Vaccinia-Induced Early Anti-Tumour Immune Responses Are Dependent on Differential Reprogramming of Myeloid Cell Populations in Highly Versus Weakly Immunogenic Murine Cancer Models |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) | INEC Main Auditorium |
| 7:00–8:00 PM | Social Hour with Lite Bites | INEC Foyer |
| 8:00–9:00 PM | Cash Bar | INEC Foyer |
| 7:00–11:59 PM | Departure |